FAQs – Migraine & Pain
Some common questions you might have about the Montreal Neurotherapy Center.
HEG Neurofeedback (Hemoencephalography) involves placing an infrared sensor on the middle of the forehead. The sensor gives a reading of the blood flow in your brain in the frontal lobe of your brain. A week blood flow in the frontal lobe is associated with lower oxygen level deliver to the brain resulting in persistent migraines.
HEG Training Sessions:
- Typical Session duration can vary from 45 minutes to an Hour, depending on the patient.
- 2-3 times weekly in frequency show the best benefits
- Can be as long as few months to a year
All treatments plans are individualized at the Montreal Neurotherapy Center. The Goal of each HEG training session is to help the Patient train his or her brain to conscientiously elevate the blood flow in the frontal lobe to increase the amount of oxygen in the frontal lobe using the live signals generated by the HEG Sensors.
The PainX™ tDCS System is a non-invasive therapy approved in Canada for the treatment of migraine and fibromyalgia. PainX™ tDCS is the first and only tDCS based system approved for the safe and effective clinical treatment of pain disorders. Montreal Neurotherapy Center is the first private center in Canada to offer this treatment.
What does tDCS mean?
It’s an abbreviation for Transcranial Direct Current Stimulation.
How does tDCS work?
Patients receive PainX™ tDCS at Our office based on a personalized schedule that is convenient to them. Most choose to have the stimulation therapy 3 to 5 times a week. While you sit, electrode patches are applied to the head using a specially designed cap or strap. Wires connect the patches to a small battery-powered device that can be placed on a table next to you. For about 20 minutes, mild direct electrical current (DC) then stimulate specific positions of our brain to reduce the pain. Patients typically report a mild tingling sensation during the session that stops at the end.
How tDCS can help migraine?
Direct Current Transcranial Magnetic Stimulation (tDCS) is a non-invasive medical device developed by physicians and researchers in NYC, as an adjunctive treatment for fibromyalgia and migraine. It is designed to provide a safe and effective migraine treatment without the risks or complications of surgery.
Evidence shows that the experience of pain is linked to EEG, or brain wave activity. Teaching patients to alter EEG activity to reflect activity that has been shown to be associated with reduced pain may be promising.
Chronic pain is associated with pathologically altered brain activity and morphology. Some studies have found abnormalities in the Electrophysiological (brainwave) activity in migraine patients, which suggest that training the brain to alter its electrophysiological activity in certain frequency bands might be effective.